I made yet another shares purchase today and this time round, the company picked was C&O Pharmaceutical Technology Limited [E92.SI].
The main reason why I bought this C&O is due to impressive to-come dividends. As anticipated by Philip Research, 4Q dividend could be at S$0.012 which makes the whole year dividend to be at S$0.08. If we were to use today's S$0.47/share, it would be 17%! This very healthy net cash comes after they sold Hong kong asset, which add to their EPS.
1 past dividend and 1 coming soon
Ex Date: 26 Aug 2010 SGD 0.028
Ex Date: 12 Jul 2010 SGD 0.005
Ex Date: 12 Jul 2010 SGD 0.035
This China-based drug maker's strong R&D capability provides springboard to launch new products, paving way for expansion in local and international markets. According to CIMB analyst, C&O is also an attractive partner to foreign drug companies looking to enter the China market.
Stay invested for the dividends remain my key investment strategy.
Subscribe to:
Post Comments (Atom)
Popular Posts
-
I would like to apologize that sigining of my guestbook is not possible at the moment due to an unexpected bug. There is already 74 entries ...
-
Singapore's Land Transport Authority has just released an updated official MRT map including one additional station on the Downtown Line... -
*********** Try to sleep now, close your eyes Soon the birds would stop singing Twinkling stars, are shining bright They'll be watch...
-
POLLING Day next Saturday will be a public holiday as Singaporeans go to the polls to cast their votes in Singapore's 11th General Elect...
-
Installed FortiClient recently but the challenge in disabling the application/service from running automatically on every start-up annoyed m...
No comments:
Post a Comment
Do provide your constructive comment. I appreciate that.